Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Hinyokika Kiyo. Acta Urologica Japonica|March 23, 2004
[A case of brain metastasis associated with prostate cancer]Norihito Soga, Yoshiki SugimuraHinyokika Kiyo. Acta Urologica Japonica|June 6, 2003
[Spermatocele associated with cholesterol crystals]Norihito Soga, Yoshiki SugimuraGan to Kagaku Ryoho. Cancer & Chemotherapy|March 14, 2007
[Optimal treatment for elderly high-risk prostate cancer patients]Norihito Soga, Yoshiki SugimuraNihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 29, 2004
[Analysis of changes in lower urinary tract symptoms with aging]Norihito Soga, Yoshiki SugimuraJapanese Journal of Clinical Oncology|August 14, 2008
Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockadeNorihito Soga, Kiminobu Arima, Yoshiki SugimuraInternational Journal of Urology : Official Journal of the Japanese Urological Association|July 25, 2008
Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinomaNorihito Soga, Kiminobu Arima, Yoshiki SugimuraInternational Journal of Clinical Oncology|March 25, 2010
Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancerNorihito Soga, Hideaki Kise, Kiminobu Arima, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|August 18, 2009
A case of renal mucinous tubular and spindle cell carcinomaManabu Kato, Norihito Soga, Kiminobu Arima, et al.International Journal of Clinical Oncology|April 17, 2010
A case of local advanced penile cancer treated with multimodality therapyManabu Kato, Norihito Soga, Kiminobu Arima, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|April 14, 2007
Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapyNorihito Soga, Takehisa Onishi, Kiminobu Arima, et al.Pageof 18